Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

SKU ID : GIR-GIR1810160449 12542213

Publishing Date : 06-Nov-2018

No. of pages : 123

PRICE
3480
6960


  • Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.



    Scope of the Report:

    This report studies the Pneumonia market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pneumonia market by product type and applications/end industries.

    Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.

    The global Pneumonia market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pneumonia.

    Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



    Market Segment by Companies, this report covers

    Pfizer

    GlaxoSmithKline(GSK)

    Merck

    Novartis

    Sanofi

    Eli Lilly



    Market Segment by Regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

    South America (Brazil, Argentina, Colombia)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



    Market Segment by Type, covers

    Drugs

    Vaccines

    Oxygen Therapy



    Market Segment by Applications, can be divided into

    Hospitals

    Ambulatory Surgical Centers

    Others